COCP News and Press, Cocrystal Pharma Inc. From 06/14/21

BOTHELL, Wash., June 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication mach...

Over the next two Fridays, The FTSE Russell will post updates to its equity index reconstitutions that were announced last Friday. These updates and adjustments to the original lists provided could occur for a number of reasons. The reactions to stock prices impacted could be strong as these a...

BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machine...

Every time there is a major disease outbreak, one of the first questions scientists and the public ask is: “Where did this come from?” In order to predict and prevent future pandemics like COVID-19, researchers need to find the origin of the viruses that cause them. This is not a...

BOTHELL, Wash., May 28, 2021 (GLOBE NEWSWIRE) -- With great sadness, Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”) announces that Gary Wilcox, Ph.D., Chairman, CEO and co-founder, suddenly passed away Wednesday, May 26 at the a...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biotechnology company Cocrystal Pharma  (NASDAQ: COCP ) focuses on developing drugs to fight viruses. So obviously, the onset of the novel coronavirus brought traders’ attention to COCP stock...

A portfolio of anti-viral products with novel mechanisms of action. The company has six antiviral products in development for Hepatitis C, Influenza, COVID-19, and Norovirus that are in development both as cocktails or monotherapies. We are transferring coverage and reiterating our Buy rating ...

Cocrystal Pharma (COCP): Q1 GAAP EPS of -$0.04 in-line.Cash and cash equivalents of $33.3MPress Release For further details see: Cocrystal Pharma EPS in-line

BOTHELL, Wash., May 17, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ever since “meme stock madness” screeched to a halt, small-cap stocks have been in a slump. That’s been especially the case for speculative biotech plays. Earlier this year, speculators on platforms lik...